• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

The model of prediction of the inhibition of neuraminidases of influenza A and B based on a reduced set of energy terms

tetano

Editor, Senior Moderator
Biomed Khim. 2019 Oct;65(6):520-525. doi: 10.18097/PBMC20196506520. [h=1][The model of prediction of the inhibition of neuraminidases of influenza A and B based on a reduced set of energy terms].[/h]
[Article in Russian; Abstract available in Russian from the publisher]

Mikurova AV[SUP]1[/SUP], Skvortsov VS[SUP]1[/SUP].
[h=3]Author information[/h] 1 Institute of Biomedical Chemistry, Moscow, Russia.

[h=3]Abstract[/h] in English, Russian
The overall model for prediction of IC50 values for inhibitors of neuraminidase influenza virus A and B has been created. It combines data about IC50 values of complexes of 40 variants of neuraminidases of influenza A (7 serotypes) and B and three known inhibitors (oseltamivir, zanamivir, peramivir). The model also uses only data of enthalpy contributions to the potential energy of inhibitor/protein and substrate (MUNANA)/protein complexes. The calculation procedures are ported to use software with support of GPU accelerators, that significant decrease the computation time. The corresponding correlation coefficient (R?) for pIC50 prediction was within 0.45-0.58, the SEM values of around 0.7 (the range of used pIC50 data set is from 4.55 to 10.22).


[h=4]KEYWORDS:[/h] QSAR; computational methods; influenza virus neuraminidase; inhibitors

PMID: 31876523 DOI: 10.18097/PBMC20196506520
 
Back
Top Bottom